Brochure | August 23, 2023

Benefits Of Direct-To-Patient Supply Management

GettyImages-1310986619 patient

Historically, clinical supply teams aimed to guarantee the availability of study materials at trial sites. However, contemporary shifts in trial design, including hybrid and decentralized models, have underscored the importance of directly delivering investigational products to patients' residences.

Signant's RTSM solution empowers direct-to-patient clinical supply distributions, yielding advantages for all involved parties:

  • Alleviates patient and site responsibilities
  • Ensures comprehensive traceability
  • Enhances workflow efficiency

For deeper insights, refer to the informative brochure below.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader